157 related articles for article (PubMed ID: 11053207)
1. Non-competitive pharmacological antagonism at the rabbit B(1) receptor.
Larrivée JF; Gera L; Houle S; Bouthillier J; Bachvarov DR; Stewart JM; Marceau F
Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207
[TBL] [Abstract][Full Text] [Related]
2. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
[TBL] [Abstract][Full Text] [Related]
4. Characterization of bradykinin receptors in a human osteoblastic cell line.
Brechter AB; Lerner UH
Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
[TBL] [Abstract][Full Text] [Related]
5. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.
Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F
Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648
[TBL] [Abstract][Full Text] [Related]
6. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
[TBL] [Abstract][Full Text] [Related]
7. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor.
Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC
Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
9. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
Drapeau G; Audet R; Levesque L; Godin D; Marceau F
J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
[TBL] [Abstract][Full Text] [Related]
10. Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.
Houle S; Larrivée JF; Bachvarova M; Bouthillier J; Bachvarov DR; Marceau F
Hypertension; 2000 Jun; 35(6):1319-25. PubMed ID: 10856284
[TBL] [Abstract][Full Text] [Related]
11. Synergism between the contractile effect of epidermal growth factor and that of des-Arg9-bradykinin or of alpha-thrombin in rabbit aortic rings.
deBlois D; Drapeau G; Petitclerc E; Marceau F
Br J Pharmacol; 1992 Apr; 105(4):959-67. PubMed ID: 1504721
[TBL] [Abstract][Full Text] [Related]
12. Absence of ligand-induced regulation of kinin receptor expression in the rabbit.
Sabourin T; Guay K; Houle S; Bouthillier J; Bachvarov DR; Adam A; Marceau F
Br J Pharmacol; 2001 Aug; 133(7):1154-62. PubMed ID: 11487527
[TBL] [Abstract][Full Text] [Related]
13. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
14. Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations.
Bagaté K; Develioglu L; Imbs JL; Michel B; Helwig JJ; Barthelmebs M
Br J Pharmacol; 1999 Dec; 128(8):1643-50. PubMed ID: 10588918
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of bradykinin analogues on recombinant human bradykinin B(1) and B(2) receptors.
Simpson PB; Woollacott AJ; Hill RG; Seabrook GR
Eur J Pharmacol; 2000 Mar; 392(1-2):1-9. PubMed ID: 10748265
[TBL] [Abstract][Full Text] [Related]
17. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R
Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903
[TBL] [Abstract][Full Text] [Related]
18. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1.
deBlois D; Bouthillier J; Marceau F
Br J Pharmacol; 1991 May; 103(1):1057-66. PubMed ID: 1878745
[TBL] [Abstract][Full Text] [Related]
19. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in the contractile responses of kinins in rat portal vein rings: mediation by B1 and B2 receptors.
Campos AH; Calixto JB
J Pharmacol Exp Ther; 1994 Feb; 268(2):902-9. PubMed ID: 8114004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
